JYSZ2400050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2024-09-04 | | | | | view |
JYSZ2400024 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2024-05-14 | | | | | view |
JYSZ2400023 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2024-05-14 | | | | | view |
JYSZ2100520 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2021-06-10 | | | | | view |
JYSZ1900039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2019-07-08 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2019-11-27 | view |
JYSZ1900007 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2019-03-01 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2019-08-22 | view |
JYSB2300141 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2023-08-18 | | | | | view |
JYSB2200020 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-11 | | | | | view |
JYSB2200014 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-01-27 | | | | | view |
JYSB2101212 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-12-28 | | | | | view |
JYSB2101202 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-12-22 | | | | | view |
JYSB2101156 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-11-03 | | | | | view |
JYSB2101115 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-08-30 | | | | | view |
JYSB2101060 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-25 | | | | | view |
JYSB2101044 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-03 | | | | | view |
JYSB2101039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | | | | view |
JYSB2101038 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2021-06-02 | | | | | view |
JYSB2000487 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-30 | AbbVie Ltd | Abbvie Ltd | Filed | 2020-10-19 | view |
JYSB2000486 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-30 | AbbVie Ltd | Abbvie Ltd | Filed | 2020-10-19 | view |
JYSB2000349 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2020-09-17 | view |